Literature DB >> 3977489

Campylobacter fetus subspecies fetus bacteremia.

P Francioli, J Herzstein, J P Grob, J J Vallotton, G Mombelli, M P Glauser.   

Abstract

Eight patients with Campylobacter fetus bacteremia, six of them with serious underlying diseases, were seen in a two-year period. Besides fever, which was observed in all cases, the most frequent clinical manifestation was lower extremity phlebitis and cellulitis (four patients). In one of these patients, it had the peculiar aspect of bilateral pretibial cellulitis. One patient had vertebral osteomyelitis, a complication, to our knowledge, not yet described. Two patients, both with advanced underlying diseases, died. The five patients who completed a two- to three-week course of erythromycin gluceptate, all had initial clinical improvement. However, one patient suffered a relapse at the end of treatment, and progression of vertebral osteomyelitis while on erythromycin therapy was observed in another patient. These clinical and bacteriologic failures occurred despite the in vitro sensitivity to erythromycin of the two strains. This suggests that erythromycin might not be adequate therapy for C fetus septicemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977489

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  24 in total

1.  Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000.

Authors:  Carole Tremblay; Christiane Gaudreau; Manon Lorange
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

2.  Campylobacter fetus peritonitis and bacteremia in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  M P Romero Gómez; A García-Perea; G Ruiz Carrascoso; M A Bajo; J Mingorance
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

3.  Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.

Authors:  C Tremblay; C Gaudreau
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

4.  Campylobacter fetus cholangitis and bacteremia.

Authors:  J Douketis; D E Low
Journal:  CMAJ       Date:  1989-11-01       Impact factor: 8.262

5.  Pathogenesis of Campylobacter fetus infections. Role of surface array proteins in virulence in a mouse model.

Authors:  Z Pei; M J Blaser
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

6.  Campylobacter fetus bloodstream infection: risk factors and clinical features.

Authors:  L Gazaigne; P Legrand; B Renaud; B Bourra; E Taillandier; C Brun-Buisson; P Lesprit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-13       Impact factor: 3.267

Review 7.  A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature.

Authors:  A Monselise; D Blickstein; I Ostfeld; R Segal; M Weinberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-24       Impact factor: 3.267

8.  Campylobacter fetus meningitis in a diabetic adult cured by imipenem.

Authors:  J Herve; N Aissa; P Legrand; M Sorkine; M J Calmette; A Santin; E Roupie; B Renaud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-20       Impact factor: 3.267

Review 9.  Recovery of uncommon bacteria from blood: association with neoplastic disease.

Authors:  J L Beebe; E W Koneman
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

10.  Campylobacter fetus subspecies fetus infection.

Authors:  F Allerberger; M J Kasten; J P Anhalt
Journal:  Klin Wochenschr       Date:  1991-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.